Artemis MRI/ TRUS Fusion Prostate Biopsy solution

What is the Artemis MRI/ TRUS Fusion Prostate Biopsy solution?

TRUS stands for Transrectal Ultrasonography. It is a medium for capturing and creating the outlook image of the prostate gland with the help of ultrasound procedures.

The Artemis MRI/TRUS Fusion is a revolutionary imaging and 3D navigation ...

Why is the technology unique?

The technology includes a semi-robotic arm that allows the doctor to delivers quality samples of the most difficult areas within the prostate. The remote centre of motion minimises prostate deforma...

How does it help?

An accurate prostate tumour diagnosis and appropriate treatment depend on the ability to efficiently perform the biopsy on specific areas of the prostate. By fusing the MRI and live ultrasound images, the doctors at Medanta can more effectively perform a targeted biopsy of select tissue. The biopsy results then lead to a more accurate diagnosis along with better information to help you make a smarter, more individualised choice about your treatment.

What are the benefits and risks of a TRUS Biopsy ?

This technology allows the doctors at Medanta to use MRI and TRUS images to sample precise areas of the prostate and to record biopsy locations for future reference in their diagnosis and management.

Benefits
Risks

Smart prostate biopsy procedure that comprises 3D prostate visualisation, precise needle tracking and biopsy location recording for future reference
Detailed 3D imaging which provides precise location of suspicious tissue and/or cancer lesions and generates advance clinical inf

Infection: This is more common in men who have undiagnosed prostatitis and/or urinary tract infection. Usually, antibiotic medication before the biopsy prevents infection
Bleeding per urethra: This can cause blood clots, inability to urinate or need to urinate more often

How does Medanta provide care?

Medanta Kidney and Urology Institute offers some of the regions finest experts covering every aspect of urology. We are continuously working to develop new directions for the treatment of cancer ...